is semaglutide in ozempic
Skip Prescription Weight Loss: Try Tirzepatide
In the SURPASS-3 trial tirzepatide delivered a 22.5% average weight loss after 72 weeks, outperforming semaglutide and making it a strong first-line option for prescription weight loss. I see the data as a clear signal that clinicians can safely move past older GLP-1 agents when a more potent drug